Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-MAPTRx in Patients With Mild Alzheimer's Disease
Clinical trial NCT03186989 · COMPLETED
Trial details
- NCT number
- NCT03186989
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-12
- Primary completion
- 2022-05-12
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.